News
CPHI
0.5347
-2.96%
-0.0163
Weekly Report: what happened at CPHI last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at CPHI last week (1026-1030)?
Weekly Report · 11/02 10:25
Weekly Report: what happened at CPHI last week (1019-1023)?
Weekly Report · 10/26 10:24
Weekly Report: what happened at CPHI last week (1012-1016)?
Weekly Report · 10/19 10:24
Weekly Report: what happened at CPHI last week (1005-1009)?
Weekly Report · 10/12 10:30
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 10/08 12:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 10/07 21:06
Weekly Report: what happened at CPHI last week (0928-1002)?
Weekly Report · 10/05 10:30
Weekly Report: what happened at CPHI last week (0921-0925)?
Weekly Report · 09/28 10:24
Weekly Report: what happened at CPHI last week (0914-0918)?
Weekly Report · 09/21 10:25
Weekly Report: what happened at CPHI last week (0907-0911)?
Weekly Report · 09/14 10:30
Weekly Report: what happened at CPHI last week (0831-0904)?
Weekly Report · 09/07 10:23
Weekly Report: what happened at CPHI last week (0824-0828)?
Weekly Report · 08/31 10:31
Weekly Report: what happened at CPHI last week (0817-0821)?
Weekly Report · 08/24 10:32
Weekly Report: what happened at CPHI last week (0810-0814)?
Weekly Report · 08/17 10:33
Weekly Report: what happened at CPHI last week (0803-0807)?
Weekly Report · 08/10 10:27
Weekly Report: what happened at CPHI last week (0727-0731)?
Weekly Report · 08/03 10:27
Weekly Report: what happened at CPHI last week (0720-0724)?
Weekly Report · 07/27 10:32
China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering
PR Newswire · 07/23 22:49
China Pharma Holdings Announces New Capital Raising Agreement
TipRanks · 07/22 21:48
More
Webull provides a variety of real-time CPHI stock news. You can receive the latest news about China Pharma through multiple platforms. This information may help you make smarter investment decisions.
About CPHI
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.